Optimal formula of urinastatin vaginal suppository and it’s clinical usefulness

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: SATAKE, Kiyoshi (Saitama Redcloss Hospital, Hospital, saitamasi, Japan)
  • Co-author(s): Kiyoshi Satake: Department of Pharmacy, Japanese Red Cross Saitama Hospital, saitama, Japan
    Hideaki Monchusho: Department of Pharmacy, Japanese Red Cross Saitama Hospital, saitama, Japan
    Takanori Nakajima: Department of Clinical Pharmaceutics, Nihon Pharmaceutical University, saitama, Japan
    Masanori Iwata: Department of Clinical Pharmaceutics, Nihon Pharmaceutical University, saitama, Japan
    Mitsuru Machida: Department of Pharmacy, Japanese Red Cross Saitama Hospital, saitama, Japan
    Sumitaka Miyamoto: Department of Obstetrics and Gynecology, Japanese Red Cross Saitama Hospital, saitama, Japan
    Manabu Nakamura: Department of Obstetrics and Gynecology, Japanese Red Cross Saitama Hospital, saitama, Japan
    Akihiko Ando: Department of Obstetrics and Gynecology, Japanese Red Cross Saitama Hospital, saitama, Japan
  • Abstract:

    Background

    N-US">In Japan an urinastatin vaginal suppository (UVS) is used to delay impending premature birth. It is not commercially available, is prepared by pharmacist as a hospital preparation.

    Purpose

     We investigated optimized formula of UVS and its clinical usefulness.

    Methods

     (1) Preparation: An optimal prescription was examined based on the..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login